Portal for life science/healthcare startups
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device >
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • 全般 >
        • PMDA RS相談活用のススメ
        • 薬事スタッフ・コンサル選定ガイド
        • 都道府県薬務課一覧
        • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • 医薬品、再生医療等製品 >
        • 医薬品の該当性確認方法
        • 医薬品一般的名称設定のガイドライン
        • 先進医療制度
        • 一般用医薬品(OTC)
      • 医療機器 >
        • 医療機器該当性確認ガイド
        • 医療機器と非医療機器の機能が複合した製品は?
        • 医療機器の一般的名称と確認方法
        • 医療機器のクラス分類
        • 医療機器・体外診の保険収載
        • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報

J-Ships:JSDA Shares and Investment trusts for Professionals

This page provides a simple and concise explanation of the recently noted J-Ships (Professional Investor Oriented Securities System), including its overview, merits, and demerits.


Overview 
J-Ships (an acronym for JSDA Shares and Investment trusts for Professionals) is a system operated by the Japan Securities Dealers Association (JSDA) that allows only "Professional Investors" (so-called "pro investors") to buy and sell shares, etc., of non-listed companies (unlisted companies).
It differs from an "listing (IPO)" on a regular stock exchange (like the Tokyo Stock Exchange). It is a mechanism that provides a "venue" and "rules" for professional investors to trade unlisted shares among themselves, mediated by securities firms, through simpler procedures than an IPO.
Its purpose is to support the financing of growth companies such as venture businesses and mid-sized enterprises, and to provide new investment opportunities to professional investors.


Merits
J-Ships offers merits to both the "corporate side" (issuers) seeking funds and the "investor side" seeking to invest.

Merits for the Corporate Side (Issuers)
Swift Fundraising: Compared to an IPO (listing), the hurdles for procedures and examinations are lower, making it possible to raise funds faster and at a lower cost.
Reduced Disclosure Burden: Since it does not require disclosure as strict as an IPO, administrative costs can be kept down.

Merits for the Investor Side (Professional Investors)
New Investment Opportunities: It creates chances to invest from an early stage in promising unlisted companies that are usually difficult to invest in.


Demerits / Cautions 
While there are merits, there are also significant risks, especially for the investor side.

Demerits for the Corporate Side (Issuers)

Limited Buyers: Because buyers are limited to professional investors, it may be difficult to raise large-scale funds from a wide range of general retail investors as one would with an IPO.

Demerits for the Investor Side (Professional Investors)

High Investment Risk: The investments are in unlisted companies, which often lack the strict audits or information disclosure of listed companies, carrying an extremely high risk of bankruptcy and stock price volatility.
Low Liquidity: Unlike an exchange, there is not always a counterparty available for transactions, making it highly possible that one "cannot sell when wanting to sell" or "cannot buy when wanting to buy" (low liquidity).
Information Asymmetry: Because the disclosed information is limited, making investment decisions becomes difficult.


Related Links
For more detailed information about the system, please check the official website of the Japan Securities Dealers Association.
https://market.jsda.or.jp/shijyo/j-ships/ 


@K.Kamitani
Home
About JPRO
Table of Contents
​
​オフィス概要
​コンテンツ一覧
JPRO is a Japan-based business incubator for startups. 
​
Our approach is unique because our primary focus is on enabling startup self-sufficiency. Our core mission is to help startups optimize their time and cost-efficiency, ensuring they avoid unnecessary expenses and delays. We achieve this by providing centralized access to essential, high quality information—all completely free of charge.
​
The reliability of our content is exceptionally high, as our information is sourced directly from public institutions and the advice mirrors what we provide in our official advisory roles within these very organizations.
​"You'll likely gain a clear understanding of what needs to be done, enabling you to manage many aspects of your business in-house."
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device >
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • 全般 >
        • PMDA RS相談活用のススメ
        • 薬事スタッフ・コンサル選定ガイド
        • 都道府県薬務課一覧
        • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
      • 医薬品、再生医療等製品 >
        • 医薬品の該当性確認方法
        • 医薬品一般的名称設定のガイドライン
        • 先進医療制度
        • 一般用医薬品(OTC)
      • 医療機器 >
        • 医療機器該当性確認ガイド
        • 医療機器と非医療機器の機能が複合した製品は?
        • 医療機器の一般的名称と確認方法
        • 医療機器のクラス分類
        • 医療機器・体外診の保険収載
        • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報